Personal tools

Coexpression cluster:C1755

From FANTOM5_SSTAR

Revision as of 14:15, 21 May 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C1755_Reticulocytes_hepatoblastoma_acute_bone_epidermoid_Myoblast_merkel



Phase1 CAGE Peaks

Hg19::chr15:91537708..91537721,-p3@PRC1
Hg19::chr15:91537723..91537804,-p1@PRC1
Hg19::chr15:91537809..91537824,-p2@PRC1
Hg19::chr20:30327143..30327154,+p2@TPX2
Hg19::chr2:234763105..234763145,-p2@HJURP


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0005819spindle0.000260211140050149
GO:0000278mitotic cell cycle0.00147177864353539
GO:0051231spindle elongation0.00147177864353539
GO:0000022mitotic spindle elongation0.00147177864353539
GO:0015630microtubule cytoskeleton0.00231158995183011
GO:0022402cell cycle process0.00281613787933062
GO:0007049cell cycle0.00404685512039531
GO:0007052mitotic spindle organization and biogenesis0.00404685512039531
GO:0044430cytoskeletal part0.00405237908315862
GO:0005876spindle microtubule0.00508305403775861
GO:0007051spindle organization and biogenesis0.00508305403775861
GO:0005856cytoskeleton0.00701625588815873
GO:0000922spindle pole0.00701625588815873
GO:0000910cytokinesis0.00714527213891618
GO:0000226microtubule cytoskeleton organization and biogenesis0.0199867284173438
GO:0043232intracellular non-membrane-bound organelle0.0217224388160334
GO:0043228non-membrane-bound organelle0.0217224388160334
GO:0007067mitosis0.0335824835975614
GO:0000087M phase of mitotic cell cycle0.0335824835975614
GO:0051301cell division0.0335824835975614
GO:0044446intracellular organelle part0.0335824835975614
GO:0044422organelle part0.0335824835975614
GO:0005874microtubule0.0369179559006534
GO:0000279M phase0.0369179559006534
GO:0007017microtubule-based process0.0369179559006534
GO:0022403cell cycle phase0.0415502081008049



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br><br>disease_data<br>


Cell Type
Ontology termp-valuen
epithelial cell1.09e-17254
animal cell3.41e-16679
eukaryotic cell3.41e-16679
embryonic cell7.50e-08248
non-terminally differentiated cell9.85e-08180
native cell1.12e-07722
squamous epithelial cell1.46e-0762
Disease
Ontology termp-valuen
cancer1.56e-58235
disease of cellular proliferation3.17e-57239
cell type cancer1.51e-34143
carcinoma5.71e-25106
organ system cancer4.50e-24137
hematologic cancer2.24e-1251
immune system cancer2.24e-1251
leukemia1.65e-1039
disease of anatomical entity1.13e-0839
myeloid leukemia7.76e-0831
sarcoma2.03e-0720


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.